Statement : * The emerging Coronavirus 2019 (COVID-19) disease, linked to the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathogen, has been spreading worldwide since December 2019, affecting millions of people and causing hundreds of thousands of deaths, particularly among the elderly. * The first epidemiological evidence available reveals a different expression of the disease in the elderly, associated with a high risk of delayed diagnosis and implementation of protective measures and a particularly high morbidity and mortality, especially among the frailest. * To date, there is no effective model for predicting the severity of COVID-19 in an individual. The investigators hypothesize that there are specificities of COVID-19 in the elderly, both etiological, diagnostic and prognostic, all of which are not yet known and understood.
Study Type
OBSERVATIONAL
Enrollment
700
Angers University Hospital
Angers, France
Medical history and co-morbidities
listing of medical history and co-morbidities data provided by the physician and the family during hospitalization
Time frame: baseline
The physical examination data, and reports of relevant investigations data provided by the physician and the family during hospitalization
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
Time frame: baseline
Electrocardiography QT Interval
all electrocardiograms performed during hospitalization
Time frame: baseline
Number of different therapeutic classes
Number of different therapeutic classes taken per day.
Time frame: baseline
Comprehensive Geriatric Assessment (CGA)
Comprehensive geriatric assessment (CGA) is defined as a multidisciplinary diagnostic and treatment process that identifies medical, psychosocial, and functional capabilities of an older adult in order to develop a coordinated plan to maximize overall health with aging. CGA is based on the premise that a systematic evaluation of frail older persons by a team of health professionals may identify a variety of treatable health problems and lead to better health outcomes.
Time frame: baseline
Biological parameters
Characterization of the COVID-19 impact on the biological parameters evaluated by blood test.
Time frame: baseline
Medical imaging results
Assessment of lesion extension (percent) with medical imaging results (thoracic scan)
Time frame: baseline
Diagnosis of COVID-19
Recovery of the diagnosis method (PCR or thoracic scan)
Time frame: baseline
Length of hospitalization
Time frame: at the 3-month follow-up
Number of death from any cause
Time frame: at the 3-month follow-up
Reports of relevant investigations data provided by the physician and the family during the two-month telephone follow-up
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
Time frame: at the 3-month follow-up
Length of hospitalization
Time frame: at the 12-month follow-up
Number of death from any cause
Time frame: at the 12-month follow-up
Reports of relevant investigations data provided by the physician and the family during the two-month telephone follow-up
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
Time frame: at the 12-month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.